{
  "12570275.json": {
    "title": "Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8)",
    "expert_findings": {
      "strengths": [
        "Normality checks (Shapiro-Wilk) explicitly stated",
        "Proportional hazards assumption checked (Schoenfeld residuals)",
        "ITT approach used",
        "Interaction and subgroup analyses performed"
      ],
      "gaps": [
        "No explicit correction for multiplicity despite multiple secondary endpoints and subgroup analyses",
        "Blinding description lacks detail on allocation concealment process",
        "Sample size calculation uses 'approximate' rates which could be more precise"
      ],
      "overall_rigor_rating": "Medium-High"
    }
  },
  "12660148.json": {
    "title": "Spatial multiomic landscape of the human placenta at molecular resolution",
    "expert_findings": {
      "strengths": [
        "Multiplicity correction (Benjamini-Hochberg) for spatial autocorrelation",
        "FDR adjustment for marker identification"
      ],
      "gaps": [
        "Sample size justification lacks power calculation details",
        "Blinding not explicitly described (noted as not relevant)"
      ],
      "overall_rigor_rating": "High"
    }
  },
  "12618242.json": {
    "title": "A multimodal whole-slide foundation model for pathology",
    "expert_findings": {
      "strengths": [
        "Multiplicity correction (Tukey) for pairwise comparisons",
        "Accounted for data dependency using GLMM models",
        "Bootstrapping for performance reporting"
      ],
      "gaps": [
        "Sample size lacks power calculation (common in ML studies)",
        "P-values reported without effect size metrics"
      ],
      "overall_rigor_rating": "High"
    }
  },
  "12505835.json": {
    "title": "Population based cohort study of routinely collected data in electronic health records",
    "expert_findings": {
      "strengths": [
        "Large population-based cohort using routinely collected EHR data",
        "Standardized reporting according to RECORD/STROBE guidelines",
        "Used mixed effects negative binomial regression and linear mixed effects models",
        "Adjusted for several fixed effects (age, ethnicity, IMD, region, family history, etc.)",
        "Included random intercepts for practices (clustering)",
        "Sensitivity analyses performed"
      ],
      "gaps": [
        "No explicit power calculation for the cohort study",
        "No explicit correction for multiplicity mentioned despite many fixed effects and subgroup analyses",
        "Imputation for missing data was NOT performed (potential gap in rigor)"
      ],
      "overall_rigor_rating": "Medium"
    }
  },
  "12603894.json": {
    "title": "Vernakalant versus procainamide for acute atrial fibrillation: a randomised clinical trial (RAFF3)",
    "expert_findings": {
      "strengths": [
        "Superiority trial with a clearly defined primary outcome",
        "Sample size calculation explicitly performed (80% power, 15% difference)",
        "Intention-to-treat (ITT) analysis",
        "Multiple logistic regression used, adjusting for stratification and prognostic variables",
        "Handled clustering by site as a random effect",
        "Secondary outcomes used appropriate models (logistic, linear, Cox PH)",
        "Subgroup analyses (planned a priori) with interaction terms"
      ],
      "gaps": [
        "No explicit mention of multiplicity correction for secondary endpoints",
        "Blinding details are thin for treating physician and patient"
      ],
      "overall_rigor_rating": "High"
    }
  },
  "12607009.json": {
    "title": "Continued versus discontinued oral anticoagulant treatment for unprovoked venous thromboembolism: target trial emulation",
    "expert_findings": {
      "strengths": [
        "Used target trial emulation framework to reduce bias in observational data",
        "1:1 propensity score matching using 89 baseline covariates",
        "Absolute standardized mean difference (ASMD) used to verify covariate balance",
        "Cox proportional hazards models with PH assumption checked",
        "Random effects meta-analysis for pooling database results",
        "Extensive sensitivity analyses (HDPS, E-value, Fine and Gray for competing risks)"
      ],
      "gaps": [
        "No explicit mention of power calculation for the emulated trial",
        "No explicit correction for multiplicity mentioned for subgroup analyses"
      ],
      "overall_rigor_rating": "High"
    }
  },
  "12618225.json": {
    "title": "Effects of volenrelaxin in worsening heart failure with preserved ejection fraction: a phase 2 randomised trial",
    "expert_findings": {
      "strengths": [
        "Used Mixed Model for Repeated Measures (MMRM) to handle longitudinal data",
        "Blinded adjudication of clinical endpoints by an independent committee",
        "Interim analyses planned and reviewed by an independent assessment committee"
      ],
      "gaps": [
        "Explicitly stated that no adjustment for multiplicity was performed",
        "Imputation for missing data not explicitly described for main endpoints"
      ],
      "overall_rigor_rating": "Medium-High"
    }
  },
  "12705426.json": {
    "title": "Sonelokimab, an IL-17A/IL-17F-inhibiting nanobody for active psoriatic arthritis: a randomized, placebo-controlled phase 2b trial (ARGO)",
    "expert_findings": {
      "strengths": [
        "Highly rigorous multiplicity control using hierarchical order and Bonferroni-Holm",
        "Intention-to-treat (ITT) population used for efficacy analyses",
        "Explicit handling of missing data using Non-Responder Imputation (NRI) or MMRM"
      ],
      "gaps": [
        "Includes exploratory or post hoc analyses (composites) which may inflate type I error",
        "Sample size justification lacks explicit power calculation details"
      ],
      "overall_rigor_rating": "High"
    }
  },
  "12628362.json": {
    "title": "Targeted therapy in advanced BRAF-mutated colorectal cancer: systematic review and network meta-analysis",
    "expert_findings": {
      "strengths": [
        "Used Bayesian network meta-analysis framework with credible intervals",
        "Evaluated rankings using systematic review metrics (SUCRA, rankograms)",
        "Assessed transitivity and inconsistency using appropriate methods"
      ],
      "gaps": [
        "Network fragmentation or fragmentation issues mentioned",
        "Multiplicity correction not explicitly mentioned for multiple treatment comparisons"
      ],
      "overall_rigor_rating": "High"
    }
  },
  "12705454.json": {
    "title": "A consensus blood transcriptomic framework for sepsis",
    "expert_findings": {
      "strengths": [
        "Machine learning (Random Forest) for classification with cross-validation",
        "Association evaluated using Jaccard similarity and bootstrapping",
        "Propensity score matching used to evaluate corticosteroid impact"
      ],
      "gaps": [
        "No statistical method used to predetermine sample size (no power calculation)",
        "Multiplicity correction not explicitly mentioned for all high-dimensional comparisons"
      ],
      "overall_rigor_rating": "High"
    }
  },
  "12618238.json": {
    "title": "Pridopidine in early-stage manifest Huntington's disease: a phase 3 trial",
    "expert_findings": {
      "strengths": [
        "Rigorous Phase 3 RCT design with 94% power calculation",
        "Advanced missing data handling using MNAR and pattern mixture models (PMM)",
        "MMRM used for longitudinal outcomes",
        "Pre-specified subgroup analyses (e.g., ADM use, disease stage)"
      ],
      "gaps": [
        "Post hoc responder and CDF analyses which may inflate type I error",
        "No explicit multiplicity correction for multiple secondary endpoints"
      ],
      "overall_rigor_rating": "High"
    }
  },
  "7618460.json": {
    "title": "A phase 1 randomized, placebo-controlled trial of a combination typhoid and non-typhoidal polysaccharide conjugate vaccine",
    "expert_findings": {
      "strengths": [
        "Phase 1 first-in-human trial with blinded study product",
        "Immunogenicity analyzed for all participants with available data"
      ],
      "gaps": [
        "Explicitly stated that no formal power calculations were performed",
        "No multiplicity adjustment for multiple immunogenicity markers and time points",
        "No imputation for missing data"
      ],
      "overall_rigor_rating": "Medium-High"
    }
  },
  "12705427.json": {
    "title": "Brain activity associated with breakthrough food preoccupation in an individual on tirzepatide",
    "expert_findings": {
      "strengths": [
        "Innovative N=1 case study using permutation testing and cluster correction",
        "Responsive deep brain stimulation (rDBS) with iEEG recording biomarker discovery"
      ],
      "gaps": [
        "N=1 case study limits generalizability and statistical power",
        "Potential recall bias and confounded data exclusion (montage changes)",
        "No explicit multiplicity correction for full power spectrum analysis"
      ],
      "overall_rigor_rating": "Medium"
    }
  },
  "12618236.json": {
    "title": "Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: phase 1 AMPLIFY-201 trial final results",
    "expert_findings": {
      "strengths": [
        "Molecular response assessment using ctDNA (Natera Signatera)",
        "Used Mann-Whitney, Kaplan-Meier, and log-rank tests appropriately",
        "ROC analysis for predictive accuracy"
      ],
      "gaps": [
        "Multiplicity correction missing for multiple immune assays and neoantigens",
        "No mention of proportional hazards (PH) assumption check for RFS"
      ],
      "overall_rigor_rating": "High"
    }
  },
  "12618248.json": {
    "title": "Heterologous two-dose Ebola vaccine regimen in pregnant women in Rwanda: a randomized controlled phase 3 trial",
    "expert_findings": {
      "strengths": [
        "Phase 3 RCT in a vulnerable population (pregnant women)",
        "Used validated and FDA-endorsed FANG ELISA assays",
        "Independent Data Monitoring Committee (IDMC) oversight"
      ],
      "gaps": [
        "Not powered for hypothesis testing (feasibility-based sample size)",
        "Multiplicity inflation acknowledged but not corrected for primary outcomes",
        "Post hoc correlation and risk difference analyses"
      ],
      "overall_rigor_rating": "High"
    }
  },
  "12705421.json": {
    "title": "Clinical validation of a 29-mRNA blood-based host response test for the diagnosis and prognosis of sepsis (TACOMA study)",
    "expert_findings": {
      "strengths": [
        "Detailed diagnostic vs prognostic population definitions",
        "Use of likelihood ratios, sensitivity, specificity, and NPV/PPV",
        "Fisher's exact test used for ICU-level care differences",
        "DeLong's test for comparing AUROCs",
        "Bootstrapping for immunocompromised vs COVID-19 comparisons",
        "SAS 9.4 and R 4.2 cited"
      ],
      "gaps": [
        "No explicit mention of multiplicity correction for secondary endpoints",
        "Sample size calculation and power analysis details missing from text"
      ],
      "overall_rigor_rating": "High"
    }
  },
  "12713919.json": {
    "title": "Treatment-response to digital CBTi in people with insomnia and high-risk of OSA: A secondary analysis of an online randomized controlled trial",
    "expert_findings": {
      "strengths": [
        "Intention-to-treat (ITT) linear mixed models",
        "Bonferroni-corrected pairwise comparisons for interaction effects",
        "Cohen's d values reported as effect sizes",
        "SPSS 28 cited"
      ],
      "gaps": [
        "Secondary analysis lacks specific power calculation for the subgroup comparison",
        "Potential bias from collapsing intervention and waitlist control groups"
      ],
      "overall_rigor_rating": "High"
    }
  },
  "12721611.json": {
    "title": "Fluoroscopy-free versus conventional retrograde intrarenal surgery: a prospective, multicenter randomized controlled trial (RAFF3)",
    "expert_findings": {
      "strengths": [
        "Non-inferiority design with justified 20% margin",
        "Explicit power calculation (80% power, n=140 planned for attrition)",
        "SAS 9.4 PROC PLAN used for randomization",
        "Allocation concealment and CONSORT adherence mentioned",
        "Normality checked and Mann-Whitney used for non-normal data",
        "Fisher's exact test used when cell counts < 5"
      ],
      "gaps": [
        "No explicit multiplicity correction for secondary endpoints"
      ],
      "overall_rigor_rating": "High"
    }
  },
  "12497947.json": {
    "title": "Immunogenicity and Safety of a Purified Vero Cell Rabies Vaccine Produced With a Next-Generation Process (PVRV-NG2): A Phase 3 Controlled Randomized Trial",
    "expert_strengths": [
      "Non-inferiority design with justified margin (-5%).",
      "Fixed-sequence method used for multiplicity correction of secondary objectives.",
      "Explicit power calculation (80% power) provided.",
      "ITT (FAS) and Per-protocol (PPAS) populations clearly defined.",
      "Detailed confidence interval methods (Wilson score, Clopper-Pearson) specified."
    ],
    "critical_gaps": [
      "Randomization sequence generation and masking details moved to supplementary materials rather than in main text methods."
    ],
    "overall_rigor": 9
  },
  "12507463.json": {
    "title": "Long-Term Outcomes of Adjuvant Trastuzumab for 9 Weeks or 1 Year for ERBB2-Positive Breast Cancer",
    "expert_strengths": [
      "Post-hoc secondary analysis of a large RCT following CONSORT guidelines.",
      "Central randomization with stratification factors (ER status, nodal status).",
      "Non-inferiority margin and original power calculation specified.",
      "Survival analysis using Kaplan-Meier, log-rank, and Cox proportional hazards with HRs.",
      "Interaction analyses for subgroup variables."
    ],
    "critical_gaps": [
      "P-values unadjusted for multiple testing (exploratory nature acknowledged).",
      "Missing power calculation for the secondary analysis endpoint specifically."
    ],
    "overall_rigor": 8
  },
  "12713889.json": {
    "title": "Sleep disturbances and psychopathology in children/adolescents",
    "expert_strengths": [
      "Large sample size (N=13,472) with Cronbach's alpha reported for scaling.",
      "Split-sample approach (S1/S2) to ensure reproducibility of findings.",
      "Multiple imputation (SPSS) used to handle non-random missing data.",
      "Hierarchical regression models used to disaggregate effects across 5 blocks.",
      "Interaction effects investigated using PROCESS macro with mean centering."
    ],
    "critical_gaps": [
      "No formal sample size/power calculation mentioned for this secondary analysis.",
      "Multiplicity correction for multiple model blocks and interaction terms not detailed."
    ],
    "overall_rigor": 8
  },
  "12727072.json": {
    "title": "BRIDGE platform for dementia research in Korea",
    "expert_strengths": [
      "Comprehensive data management and validation system (DVS) with statistician oversight.",
      "Use of Data Quality Index (DQI) for continuous monitoring of data defects.",
      "ANOVA for continuous and Chi-square for categorical data with Kruskal-Wallis for non-normal distributions.",
      "Comparison with general population (KNHANES) using matching process.",
      "Specific software versions cited (SAS EG 7.1, R 4.1.2)."
    ],
    "critical_gaps": [
      "Power calculation missing for the platform's primary cohort objectives.",
      "Strategy for handling missing data (especially in imaging/PET) not described."
    ],
    "overall_rigor": 7
  },
  "12721701.json": {
    "title": "Salivary parameters, oral health, and adiposity in children",
    "expert_strengths": [
      "Intra- and inter-examiner reproducibility assessed with ICC.",
      "Normality testing (Shapiro-Wilk) and appropriate data transformation (log/sqrt) used.",
      "Appropriate tests for data distribution (t-test vs Mann-Whitney).",
      "Spearman's correlation used to assess multicollinearity among parameters.",
      "Logistic regression models with separate inclusion of collinear variables."
    ],
    "critical_gaps": [
      "Sample size justification/power calculation missing.",
      "Variables in logistic regression blocks need more detailed definition."
    ],
    "overall_rigor": 7
  },
  "12735295.json": {
    "title": "Critical consciousness, social networks, and mental health in adolescents",
    "expert_strengths": [
      "Validated scales (PHQ-4, Flourishing) with reported internal reliability (alpha).",
      "Egocentric network features (degree, density) used in OLS regression.",
      "Assumptions of linear regression (normality of residuals, etc.) explicitly tested.",
      "Robustness check using disaggregated mental health components.",
      "Stepwise regression procedures with standardized continuous variables."
    ],
    "critical_gaps": [
      "Potential for confounding due to multicollinearity (addressed via separate models but limits integration).",
      "No power analysis provided for the complex network effects."
    ],
    "overall_rigor": 7
  },
  "12713947.json": {
    "title": "Emotion regulation and insomnia with psychiatric comorbidity",
    "expert_strengths": [
      "Structured clinical screening (MINI) and balanced group design (n=25/group).",
      "Extensive use of validated scales with current-sample reliability (alpha) reported.",
      "Bonferroni correction used for post-hoc tests after ANOVA.",
      "Effect sizes (Cohen's d) reported for all significant group differences."
    ],
    "critical_gaps": [
      "Small sample size per group (n=25) without power calculation.",
      "Normality assumption for ANOVA not explicitly verified."
    ],
    "overall_rigor": 8
  },
  "12717196.json": {
    "title": "Meta-analysis of valvular heart disease treatments",
    "expert_strengths": [
      "Follows PRISMA guidelines and RevMan 5.4.1 used for quantitative synthesis.",
      "Risk of bias assessed using Cochrane Review Manager criteria by dual reviewers.",
      "Heterogeneity assessed with Chi-square and I2 (fixed vs random effects models).",
      "Publication bias evaluated through funnel plot analysis.",
      "Trial Sequential Analysis (TSA) used to evalute power and monitoring boundaries (80% power, 5% alpha)."
    ],
    "critical_gaps": [
      "Threshold for heterogeneity (P > 0.1) is conventional but some sources recommend I2 > 50% as more robust.",
      "Descriptive analysis used when meta-analysis not possible, but criteria for 'not possible' not detailed."
    ],
    "overall_rigor": 8
  },
  "12713972.json": {
    "title": "PSG parameters in children with ADHD and OSA",
    "expert_strengths": [
      "Polysomnography performed in accredited lab following AASM technical standards.",
      "Explicit clinical definitions for OSA based on AHI thresholds (\u22655 and \u22651).",
      "Assumption verification for all tests, with non-parametric (Wilcoxon-Kruskal-Wallis) fallbacks.",
      "Bonferroni adjustment applied for pairwise comparisons between the 4 cohorts.",
      "SAS v9.4 cited for all analyses."
    ],
    "critical_gaps": [
      "No formal sample size/power calculation reported.",
      "Control group (ADHD-/OSA-) lacked normative reference data and served only as a proxy."
    ],
    "overall_rigor": 8
  },
  "12738678.json": {
    "title": "Circulating miRNAs as biomarkers for MASLD",
    "expert_strengths": [
      "Advanced liver imaging (MRI DIXON, ARFI elastography) as reference standards.",
      "Sophisticated miRNA normalization (geometric mean + spike-in spikes) and relative quantification (2^-\u0394Ct).",
      "Internal validation of regression models using optimism-corrected bootstrap (Tibshirani method).",
      "Multivariate logistic regressions adjusted for extensive confounders (age, sex, PA, markers).",
      "Stata 15.0 cited."
    ],
    "critical_gaps": [
      "Loss of information by categorizing continuous liver stiffness/fat based on the median.",
      "No formal power calculation for biomarker discovery phase."
    ],
    "overall_rigor": 9
  },
  "12618250.json": {
    "title": "AAV2i8 gene therapy for heart failure (Phase 1/2)",
    "expert_strengths": [
      "Rigorous bioanalytical assays (ddPCR, ELISpot, Western blot) for transduction and immunogenicity.",
      "Explicit definition of FAS and Safety analysis sets.",
      "Triplicate testing for antigens in ELISpot.",
      "Follows ICH-GCP and Declaration of Helsinki.",
      "SAS v9.4 cited."
    ],
    "critical_gaps": [
      "Explicitly stated that no formal hypothesis testing or power calculations were performed.",
      "Very small sample size (n=18) limits conclusions beyond feasibility."
    ],
    "overall_rigor": 6
  },
  "12673659.json": {
    "title": "Breast density notification randomized trial",
    "expert_strengths": [
      "Triple-arm RCT with allocation concealment and Oracle-based simple randomization.",
      "Co-design process with consumers and multidisciplinary experts.",
      "A priori power calculation with Bonferroni adjustment for 3 pairwise comparisons (alpha=0.017).",
      "Use of GLM (ordinal/multinomial logistic regression) and testing of proportional odds (Brant-Wald).",
      "Sensitivity analysis using MICE for missing primary outcomes."
    ],
    "critical_gaps": [
      "Complete case analysis used as primary despite sensitivity analysis with imputation.",
      "Multiple primary outcomes (3 measures of psychological outcomes) not adjusted beyond pairwise arm comparisons."
    ],
    "overall_rigor": 9
  },
  "12670246.json": {
    "title": "FIMMAC trial: surgery vs placebo vs exercise for shoulder pain",
    "expert_strengths": [
      "Surgical RCT with sham/placebo control arm.",
      "Clinical significance defined via Minimal Important Difference (MID).",
      "Mixed Model for Repeated Measurements (MMRM) to handle missing data under MAR.",
      "Strict multiplicity protection requiring BOTH primary outcomes to be significant.",
      "Internal validation via sensitivity analyses (per protocol, as treated)."
    ],
    "critical_gaps": [
      "High crossover rate (only 56/79 in ASD group fulfilled per-protocol) weakens the pragmatic comparison.",
      "Simple identity covariance structure in mixed model may not capture longitudinal correlation well."
    ],
    "overall_rigor": 9
  },
  "12723751.json": {
    "title": "PGT-A in severe male factor infertility RCT",
    "expert_strengths": [
      "RCT with ITT as primary analysis population.",
      "Power calculation using Hochberg\u2019s procedure for co-primary endpoints (LBR and cLBR).",
      "Generalised linear mixed models (GLMM) used for central effect adjustment.",
      "Non-parametric (Wilcoxon) tests used for non-normal continuous data.",
      "MICE or worst/best-case imputation for missing data."
    ],
    "critical_gaps": [
      "Normality assessment method not explicitly described beyond the choice of non-parametric test."
    ],
    "overall_rigor": 9
  },
  "12723525.json": {
    "title": "Carboplatin in triple-negative breast cancer RCT",
    "expert_strengths": [
      "Observer-blind RCT following CONSORT 2025 guidelines.",
      "Event-driven primary analysis (144 DFS events) with pre-specified power calculation.",
      "Advanced survival modeling including Schoenfeld residual tests for proportional hazards.",
      "Restricted Mean Survival Analysis (RMST) and piecewise HR when PH assumption failed.",
      "Adjustment for non-linear effects of continuous biomarkers (Ki-67) using splines."
    ],
    "critical_gaps": [
      "No formal Type I error control for multiple secondary endpoints."
    ],
    "overall_rigor": 9
  },
  "12721610.json": {
    "title": "URBANE trial: vibegron for OAB in men with BPH",
    "expert_strengths": [
      "Phase 3 double-blind trial with single-blind placebo run-in period.",
      "MMRM analysis to handle longitudinal data and missingness.",
      "Fixed-sequence testing procedure to control family-wise error rate for secondary endpoints.",
      "Centralized IWRS randomization with block stratification by multiple clinically relevant factors.",
      "High statistical power (90-94%) with clear baseline set (FAS)."
    ],
    "critical_gaps": [
      "Randomization was not stratified by site, though centralized. Responder analysis was uncontrolled."
    ],
    "overall_rigor": 9
  },
  "12713916.json": {
    "title": "Systematic review of remote CBT-I for children",
    "expert_strengths": [
      "Follows PRISMA 2020 and Cochrane Handbook standards.",
      "Dual independent reviewers for screening, data extraction, and risk of bias.",
      "Formal Risk of Bias assessment using ROB 2 tool.",
      "Comprehensive search strategy with explicit keyword set and database inclusion."
    ],
    "critical_gaps": [
      "Lack of quantitative meta-analysis (descriptive synthesis only) despite focus on RCTs."
    ],
    "overall_rigor": 8
  },
  "12721662.json": {
    "title": "STRATA trial: Cxbladder Triage for microhematuria",
    "expert_strengths": [
      "Multicenter prospective study with 12 sites and randomization (2:1).",
      "Explicit power calculation to detect reduction in cystoscopy rates.",
      "Use of prop.test in R for proportions and exact binomial CIs for validity metrics (NPV, sensitivity).",
      "Follow-up period (3-24 months) used to confirm absence of disease in non-surgical patients.",
      "Analysis done in R 4.2.10."
    ],
    "critical_gaps": [
      "Discrepancies in patient totals between validity and utility populations due to strict review criteria.",
      "Potential for misclassification if the follow-up period was too short for occult UC."
    ],
    "overall_rigor": 8
  },
  "12721647.json": {
    "title": "Psychological comorbidities in women with Fowler's syndrome",
    "expert_strengths": [
      "Standardized multidisciplinary assessment including ICS-standard invasive urodynamics.",
      "Advanced neuro-urological tests (Brown-Wickham UPP and concentric needle EMG).",
      "Semi-structured psychological interviews by a chartered psychologist using validated screens (GAD-2, PHQ-2).",
      "Data-driven choice of tests (mean/SD vs median/range) and comparative stats (\u03c72, Fisher's, t-test)."
    ],
    "critical_gaps": [
      "Clinical audit/service evaluation design rather than formal prospective protocol.",
      "Small sample sizes for specific invasive tests (n=62-79)."
    ],
    "overall_rigor": 7
  },
  "12705465.json": {
    "title": "RELATIVITY-098: Adjuvant nivolumab and relatlimab in melanoma",
    "expert_strengths": [
      "Large phase 3 RCT (n=1050) with O'Brien-Fleming alpha spending function for interim analyses.",
      "Hierarchical testing of secondary endpoints to control Type I error.",
      "Sophisticated biomarker imaging/analysis using CODEX PhenoCycler and HALO AI.",
      "Longitudinal modeling (linear mixed-effects) and non-parametric Wilcoxon tests for biomarkers.",
      "SAS and R v4.3.1 cited."
    ],
    "critical_gaps": [
      "Biomarker analyses labeled as exploratory, reducing rigor for those secondary findings."
    ],
    "overall_rigor": 9
  },
  "12705419.json": {
    "title": "EDGE-Gastric trial: domvanalimab and zimberelimab in GC/GEJC/EAC",
    "expert_strengths": [
      "Multicenter study with central PD-L1 assessment (VENTANA SP263 assay).",
      "Exact binomial Clopper-Pearson 90% CIs for ORR and log-log transformation for survival CIs.",
      "Precise AE monitoring using MedDRA v25.0 and NCI-CTCAE v5.0.",
      "SAS v9.4 cited."
    ],
    "critical_gaps": [
      "Descriptive design explicitly avoiding formal hypothesis testing or power considerations.",
      "Open-label (unblinded) and small sample size (n=41) in the reported arm."
    ],
    "overall_rigor": 7
  },
  "12714473.json": {
    "title": "Induction vs. Adjuvant Chemotherapy in NPC: A propensity-matched study",
    "expert_strengths": [
      "Use of Propensity Score Matching (PSM) with a stringent caliper (0.01) to control for selection bias.",
      "Standardized oncology endpoints (OS, FFS, LRRFS, DMFS) following RECIST.",
      "Standardized radiotherapy (IMRT) following ICRU guidelines.",
      "Cox proportional hazards model with 95% CIs and Kaplan-Meier analysis.",
      "SPSS v23.0 cited."
    ],
    "critical_gaps": [
      "Retrospective nature limits causal inference despite PSM.",
      "Categorization of continuous variables may lead to information loss."
    ],
    "overall_rigor": 8
  },
  "12713946.json": {
    "title": "Sleep Monitoring App in Military Primary Care",
    "expert_strengths": [
      "Mixed-methods pilot study evaluating both quantitative app data and qualitative PCM feedback.",
      "Approved by WRNMMC IRB.",
      "Educational components tailored to military population."
    ],
    "critical_gaps": [
      "Lack of detailed statistical methodology for quantitative outcomes in the Methods section.",
      "Non-randomized, feasibility-focused design."
    ],
    "overall_rigor": 5
  },
  "7618412.json": {
    "title": "Availability and order on sustainable food choices",
    "expert_strengths": [
      "Factorial RCT (Availability x Order) with explicit power calculation (n=1053).",
      "Robust data handling: switched to eco-quintile analysis when primary data was found to be bimodal.",
      "Welch ANOVA and Games-Howell used for unequal variances.",
      "Strict multiplicity control (p < 0.003) for secondary/exploratory outcomes.",
      "R v4.1.3 and specific packages (dplyr, ggplot2, rstatix) cited."
    ],
    "critical_gaps": [
      "Deviated from pre-specified plan for ecoscore to handle bimodal distribution."
    ],
    "overall_rigor": 9
  },
  "12647978.json": {
    "title": "Impact of an SMS intervention on nutrition in Nepal",
    "expert_strengths": [
      "Large-scale cluster-randomized trial (134 clusters) with Difference-in-Differences (DiD) ITT analysis.",
      "Cluster-level adjustments using a sandwich estimator.",
      "Concealed allocation to PIs and data collectors.",
      "Data collection using ODK with logic checks and equity tools for wealth quintiles.",
      "Stata/SE 14.2 cited."
    ],
    "critical_gaps": [
      "Significant data missingness and delays due to COVID-19 pandemic.",
      "Exposure to similar health messages in control areas (contamination)."
    ],
    "overall_rigor": 8
  },
  "12705423.json": {
    "title": "DESTINY-Breast04: T-DXd in HER2-low metastatic breast cancer",
    "expert_strengths": [
      "Phase 3 RCT (2:1) with central HER2 confirmation and blinded independent central review (BICR).",
      "Hierarchical testing procedure for OS to preserve alpha.",
      "Assumption checks: visual inspection of log-log survival functions.",
      "Independent adjudication for sensitive AEs (ILD/pneumonitis).",
      "SAS v9.3 cited."
    ],
    "critical_gaps": [
      "Open-label design. No imputation for missing data (censoring only)."
    ],
    "overall_rigor": 9
  },
  "12728524.json": {
    "title": "In silico drug target identification for NAFLD",
    "expert_strengths": [
      "Comprehensive computational pipeline (Homology modeling, docking, MD simulations, pharmacophore).",
      "Use of verified servers (SAVES v5.0) and software (AutoDock Vina, Desmond, LIGPLOT).",
      "Drug-likeness filters based on multiple established rules (Lipinski, Veber, Ghose).",
      "Free energy calculations via MM-GBSA and stability checking with PCA in R."
    ],
    "critical_gaps": [
      "Lack of experimental (in vitro/in vivo) validation for predicted leads.",
      "Strict p-value (0.01) for GEO dataset but no FDR correction mentioned."
    ],
    "overall_rigor": 8
  },
  "12727047.json": {
    "title": "Surgical RCT for post-operative management in India",
    "expert_strengths": [
      "Prospectively registered RCT (CTRI/2019/08/020879).",
      "Use of distribution-appropriate tests (t-test/Mann-Whitney) and categorical checks (\u03c72/Fisher's)."
    ],
    "critical_gaps": [
      "Brief methodology lacking power or sample size justification in the reported snippet."
    ],
    "overall_rigor": 6
  },
  "12714465.json": {
    "title": "CCND1 copy number alterations in oral cancer",
    "expert_strengths": [
      "Prospective observational study with molecular validation (Qf-PCR) and IHC correlation.",
      "Explicit cutoff (1.8 fold change) using \u0394\u0394Ct method for genetic amplification.",
      "Quantitative IHC scoring system (integrated intensity and percentage).",
      "SPSS used for \u03c72, ANOVA, and logistic regression."
    ],
    "critical_gaps": [
      "Small sample size (n=63) and single-center design."
    ],
    "overall_rigor": 8
  },
  "12714475.json": {
    "title": "Diagnostic ability of DOI for lymph node metastasis in oral cancer",
    "expert_strengths": [
      "Prospective observational study with standardized pathology (CAP protocol).",
      "Advanced multivariate modeling: multiple binary logistic regression and nomogram construction.",
      "Diagnostic validation: ROC, AUC, sensitivity, specificity, PPV, NPV, and Hosmer-Lemeshow fit.",
      "SPSS v26, STATA v14, and R v4.0.3 cited."
    ],
    "critical_gaps": [
      "Single-center tertiary care setting may limit external generalizability."
    ],
    "overall_rigor": 9
  },
  "12727006.json": {
    "title": "Clinicopathological profile of EOC in India",
    "expert_strengths": [
      "Detailed surgical assessment (PCI, SCS, CC score) and complications (Clavien-Dindo).",
      "Appropriate non-parametric (Kruskal-Wallis, Mann-Whitney) and categorical (Fisher's exact) tests.",
      "SPSS v21.0 cited."
    ],
    "critical_gaps": [
      "Purely observational/descriptive cohort; no power calculations reported."
    ],
    "overall_rigor": 7
  },
  "12727007.json": {
    "title": "Cancer incidence and trends in Bam City, Iran",
    "expert_strengths": [
      "Population-based registry data integrated with clinical/histological sources.",
      "ICD-O coding and Age-Standardized Rates (ASRs) computed using World Standard Population.",
      "Demographic context provided (population pyramids).",
      "SPSS v22 and GraphPad Prism 9 cited."
    ],
    "critical_gaps": [
      "Simple cross-sectional analysis without advanced trend modeling (joinpoint)."
    ],
    "overall_rigor": 6
  }
}